Skip to main content
. 2016 May 16;12(1):285–290. doi: 10.3892/ol.2016.4578

Figure 2.

Figure 2.

FAS and BAX gene expression variations between 5-aza-2′-deoxycytidine-treated and untreated control HT-29 cells. Reverse transcription-quantitative polymerase chain reaction data revealed that FAS gene was significantly upregulated in 5-aza-2′-deoxycytidine treated cells campared with untreated normal control cells; however, BAX gene expression was not significantly different between two groups. ***P≤0.001. Data are expressed as mean ± standard deviation. FAS, Fas cell surface death receptor; BAX, BCL2-associated X protein.